The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
Clinical trial NCT06976619 · RECRUITING
Trial details
- NCT number
- NCT06976619
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-03
- Primary completion
- 2028-10-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.